DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
Year: 2007
Type: review
Abstract: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is now frequently used in early clinical trial assessment of antiangiogenic and vascular disrupting compounds. Evidence of drug efficacy and dose-dependent response has been demonstrated with some angiogenesis inhibitors. This review highlights the critical issues that influence T(1)-weighted DCE-MRI data acquisition and analysis, identifies important areas for future development and reviews the clinical trial findings to date.
Source: British Journal of Cancer
Authors: J P B O'Connor, A Jackson, G J M Parker, G C Jayson
Language: English
Topic: MRI in cancer diagnosis
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,190
Funder: Cancer Research UK
Awards: G1539997162, G2129063294, G6044875537
OpenAlex ID: W2070580351
